Proliferation of bone tumors. An immunohistochemical investigation of Ki-67 protein expression

被引:13
作者
Stenzel, I
Posl, M
Ritzel, H
Hentz, M
Werner, M
Delling, G
机构
来源
PATHOLOGE | 1996年 / 17卷 / 01期
关键词
Ki-67; MIB-1; proliferation; osteosarcoma; low grade osteosarcoma; bone tumors;
D O I
10.1007/s002920050135
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Bone tumors represent a group of tumors of various dignity. In spite of this single tumor entities may display strong morphological resemblance to each other which can in turn result in profound difficulties in differential diagnosis. The biological behaviour of a tumor is mainly determined by its rate of proliferation. In this study the rate of proliferation of 64 bone tumors (30 high-grade central osteosarcomas, 6 low-grade osteosarcomas, 8 giant cell tumors, 8 aneurysmatic bone cysts, 5 osteoidosteomas/osteoblastomas, 7 fibrous dysplasias and 5 cases of a myositis ossificans) were analysed. Immunohistochemistry was performed on paraffin-embedded tissue sections using the MIB-1 monoclonal antibody. MIB-1 recognizes the proliferation-associated Ki-67 protein which is expressed during the active phases of the cell cycle but cannot be detected in senescent cells. Among high-grade central osteosarcomas a significantly higher rate of proliferation (average value 30%) was found in comparison with low-grade osteosarcomas and other benign intraosseous bone tumors. This approach proved to be very useful in the distinction between high-grade and low-grade osteosarcomas as well as bone-forming intraosseous tumors. However distinguishing low-grade osteosarcomas from benign bone tumors by determining only the rate of proliferation was not possible, although interestingly, the proliferative rate of myositis ossificans, a purely reactive lesion, was in the range of the values determined for high-grade osteosarcoma.
引用
收藏
页码:56 / 62
页数:7
相关论文
共 50 条
[41]   Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors [J].
Chen, Longwen ;
Yang, Bin .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2008, 27 (03) :326-332
[42]   KI-67 EXPRESSION IN VULVAR CARCINOMA [J].
HENDRICKS, JB ;
WILKINSON, EJ ;
KUBILIS, P ;
DREW, P ;
BLAYDES, SM ;
MUNAKATA, S .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1994, 13 (03) :205-210
[43]   Immunohistochemical study of Ki-67 and DNA topoisomerase II in human endometrium [J].
Ito, K ;
Sasano, H ;
Yabuki, N ;
Matsunaga, G ;
Sato, S ;
Kikuchi, A ;
Yajima, A ;
Nagura, H .
MODERN PATHOLOGY, 1997, 10 (04) :289-294
[44]   Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors [J].
Heidenreich, A ;
Schenkmann, NS ;
Sesterhenn, IA ;
Mostofi, FK ;
McCarthy, WF ;
Heidenreich, B ;
Moul, JW .
JOURNAL OF UROLOGY, 1997, 158 (02) :620-625
[45]   Standardizing evaluation of sarcoma proliferation - higher Ki-67 expression in the tumor periphery than the center [J].
Fernebro, Josefin ;
Engellau, Jacob ;
Persson, Annette ;
Rydholm, Anders ;
Nilbert, Mef .
APMIS, 2007, 115 (06) :707-712
[46]   Ki-67 is a prognostic marker for hormone receptor positive tumors [J].
Perez-Lopez, M. E. ;
Garcia-Gomez, J. ;
Alves, M. T. ;
Paradela, A. ;
Garcia-Mata, J. ;
Garcia-Caballero, T. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (10) :996-1002
[47]   The relationship between the expression of Ki-67 and the prognosis of osteosarcoma [J].
Zeng, Ming ;
Zhou, Jian ;
Wen, Lifang ;
Zhu, Yanshan ;
Luo, Yingquan ;
Wang, Wanchun .
BMC CANCER, 2021, 21 (01)
[48]   Quantifizierung von Ki-67 in PitNET („pituitary neuroendocrine tumors“)/AdenomenQuantification of Ki-67 in PitNET (pituitary neuroendocrine tumors)/adenomas [J].
Judith Klein ;
Kai Saeger ;
Wolfgang Saeger .
Die Pathologie, 2024, 45 (5) :339-343
[49]   Expression of melanocyte differentiation antigens and Ki-67 in nodal nevi and comparison of Ki-67 expression with metastatic melanoma [J].
Lohmann, CM ;
Iversen, K ;
Jungbluth, AA ;
Berwick, M ;
Busam, KJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (10) :1351-1357
[50]   The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67 [J].
Wu, YL ;
Luo, HY ;
Kanaan, N ;
Wu, JP .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2000, 76 (04) :596-604